[en] Despite significant advances in melanoma therapy, low response rates and multidrug resistance (MDR) have been described, reducing the anticancer efficacy of the administered molecules. Among the causes to explain these resistances, the decreased intratumoral pH is known to potentiate MDR and to reduce the sensitivity to anticancer molecules. Nanomedicines have been widely exploited as the carriers of MDR reversing molecules. Lipid nanocapsules (LNC) are nanoparticles that have already demonstrated their ability to improve cancer treatment. Here, LNC were modified with novel copolymers that combine N-vinylpyrrolidone (NVP) to impart stealth properties and vinyl imidazole (Vim), providing pH-responsive ability to address classical chemoresistance by improving tumor cell entry. These copolymers could be post-inserted at the LNC surface, leading to the property of going from neutral charge under physiological pH to positive charge under acidic conditions. LNC modified with polymer P5 (C18H37-P(NVP21-co-Vim15)) showed in vitro pH-responsive properties characterized by an enhanced cellular uptake under acidic conditions. Moreover, P5 surface modification led to an increased biological effect by protecting the nanocarrier from opsonization by complement activation. These data suggest that pH-sensitive LNC responds to what is expected from a promising nanocarrier to target metastatic melanoma
Research center :
Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Belgium Center for Education and Research on Macromolecules (CERM), Belgium
Disciplines :
Materials science & engineering Chemistry
Author, co-author :
Pautu, Vincent; University of Liège (ULiège), Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Center for Education and Research on Macromolecules (CERM), Belgium > University of Angers, Inserm, The National Center for Scientific Research (CNRS), Micro & Nanomedecines Translationnelles (MINT), France
Lepeltier, Elise; University of Angers, Inserm, The National Center for Scientific Research (CNRS), Micro & Nanomedecines Translationnelles (MINT), France
Mellinger, Adélie; University of Angers, Inserm, The National Center for Scientific Research (CNRS), Micro & Nanomedecines Translationnelles (MINT), France
Riou, Jérémie; University of Angers, Inserm, The National Center for Scientific Research (CNRS), Micro & Nanomedecines Translationnelles (MINT), France
Debuigne, Antoine ; University of Liège (ULiège), Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Center for Education and Research on Macromolecules (CERM), Belgium
Jérôme, Christine ; University of Liège (ULiège), Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Center for Education and Research on Macromolecules (CERM), Belgium
Clere, Nicolas; University of Angers, Inserm, The National Center for Scientific Research (CNRS), Micro & Nanomedecines Translationnelles (MINT), France
Passirani, Catherine; University of Angers, Inserm, The National Center for Scientific Research (CNRS), Micro & Nanomedecines Translationnelles (MINT), France
Language :
English
Title :
pH‐Responsive lipid nanocapsules: a promising strategy for improved resistant melanoma cell internalization
Publication date :
01 May 2021
Journal title :
Cancers
eISSN :
2072-6694
Publisher :
Multidisciplinary Digital Publishing Institute (MDPI), Switzerland
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE] The Nanofar project in the frame of the European Erasmus Mundus program French "Ligue contre le cancer" European Cooperation in Science & Technology (COST) for the Action "New diagnostic and therapeutic tools against multidrug resistant tumors"
Hodi, F.S.; O’Day, S.J.; McDermott, D.F.; Weber, R.W.; Sosman, J.A.; Haanen, J.B.; Gonzalez, R.; Robert, C.; Schadendorf, D.; Hassel, J.C.; et al. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. N. Engl. J. Med. 2010, 363, 711– 723, doi:10.1056/NEJMoa1003466.
Larkin, J.; Hodi, F.S.; Wolchok, J.D. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N. Engl. J. Med. 2015, 373, 1270–1271, doi:10.1056/NEJMc1509660.
Singh, M.S.; Tammam, S.N.; Shetab Boushehri, M.A.; Lamprecht, A. MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers. Pharmacol. Res. 2017, 126, 2–30, doi:10.1016/j.phrs.2017.07.023.
Pautu, V.; Mellinger, A.; Resnier, P.; Lepeltier, E.; Martin, L.; Boussemart, L.; Letournel, F.; Passirani, C.; Clere, N. Melanoma tumour vasculature heterogeneity: From mice models to human. J. Cancer Res. Clin. Oncol. 2019, 145, 589–597, doi:10.1007/s00432-018-2809-z.
Shain, A.H.; Bastian, B.C. From melanocytes to melanomas. Nat. Rev. Cancer 2016, 16, 345–358, doi:10.1038/nrc.2016.37.
Erin, N.; Grahovac, J.; Brozovic, A.; Efferth, T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist. Updates 2020, 53, 100715, doi:10.1016/j.drup.2020.100715.
Assaraf, Y.G.; Brozovic, A.; Gonçalves, A.C.; Jurkovicova, D.; Linē, A.; Machuqueiro, M.; Saponara, S.; Sarmento-Ribeiro, A.B.; Xavier, C.P.R.; Vasconcelos, M.H. The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist. Updates 2019, 46, 100645, doi:10.1016/j.drup.2019.100645.
Ludwig, R.J.; Boehme, B.; Podda, M.; Henschler, R.; Jager, E.; Tandi, C.; Boehncke, W.-H.; Zollner, T.M.; Kaufmann, R.; Gille, J. Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis. Cancer Res. 2004, 64, 2743– 2750, doi:10.1158/0008-5472.can-03-1054.
Jaiswal, A.R.; Liu, A.J.; Pudakalakatti, S.; Dutta, P.; Jayaprakash, P.; Bartkowiak, T.; Ager, C.R.; Wang, Z.-Q.; Reuben, A.; Cooper, Z.A.; et al. Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype. Cancer Immunol. Res. 2020, 8, 1365–1380, doi:10.1158/2326-6066.cir-19-0005.
Simon, S.; Roy, D.; Schindler, M. Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. USA 1994, 91, 1128–1132, doi:10.1073/pnas.91.3.1128.
Wei, Q.-Y.; Xu, Y.-M.; Lau, A.T.Y. Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies. Cancers 2020, 12, 2783, doi:10.3390/cancers12102783.
Lepeltier, E.; Rijo, P.; Rizzolio, F.; Popovtzer, R.; Petrikaite, V.; Assaraf, Y.G.; Passirani, C. Nanomedicine to target multidrug resistant tumors. Drug Resist. Updates 2020, 52, 100704, doi:10.1016/j.drup.2020.100704.
Heurtault, B.; Saulnier, P.; Pech, B.; Proust, J.E.; Benoit, J.P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 2002, 19, 875–880, doi:10.1023/A:1016121319668.
Garcion, E.; Lamprecht, A.; Heurtault, B.; Paillard, A.; Aubert-Pouessel, A.; Denizot, B.; Menei, P.; Benoît, J.-P. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol. Cancer Ther. 2006, 5, 1710–1722, doi:10.1158/1535-7163.mct-06-0289.
Lamprecht, A.; Benoit, J.-P. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J. Control. Release 2006, 112, 208–213, doi:10.1016/j.jconrel.2006.02.014.
Fathy Abd-Ellatef, G.-E.; Gazzano, E.; Chirio, D.; Ragab Hamed, A.; Belisario, D.C.; Zuddas, C.; Peira, E.; Rolando, B.; Kopecka, J.; Assem Said Marie, M.; et al. Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells. Pharmaceutics 2020, 12, 96, doi:10.3390/pharmaceutics12020096.
Kaushik, L.; Srivastava, S.; Panjeta, A.; Chaudhari, D.; Ghadi, R.; Kuche, K.; Malik, R.; Preet, S.; Jain, S.; Raza, K. Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance. Int. J. Pharm. 2020, 578, 119088, doi:10.1016/j.ijpharm.2020.119088.
Allard, E.; Passirani, C.; Garcion, E.; Pigeon, P.; Vessières, A.; Jaouen, G.; Benoit, J.P. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. J. Control. Release 2008, 130, 146–153, doi:10.1016/j.jconrel.2008.05.027.
Allard, E.; Huynh, N.T.; Vessières, A.; Pigeon, P.; Jaouen, G.; Benoit, J.P.; Passirani, C. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model. Int. J. Pharm. 2009, 379, 317–323, doi:10.1016/j.ijpharm.2009.05.031.
Allard, E.; Jarnet, D.; Vessières, A.; Vinchon-Petit, S.; Jaouen, G.; Benoit, J.P.; Passirani, C. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft. Pharm. Res. 2010, 27, 56–64, doi:10.1007/s11095-009-0006-0.
Huynh, N.T.; Morille, M.; Bejaud, J.; Legras, P.; Vessieres, A.; Jaouen, G.; Benoit, J.-P.; Passirani, C. Treatment of 9L Gliosarcoma in Rats by Ferrociphenol-Loaded Lipid Nanocapsules Based on a Passive Targeting Strategy via the EPR Effect. Pharm. Res. 2011, 28, 3189–3198, doi:10.1007/s11095-011-0501-y.
Huynh, N.T.; Passirani, C.; Allard-Vannier, E.; Lemaire, L.; Roux, J.; Garcion, E.; Vessieres, A.; Benoit, J.P. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma. Int. J. Pharm. 2012, 423, 55–62, doi:10.1016/j.ijpharm.2011.04.037.
Miller, C.R.; Bondurant, B.; McLean, S.D.; McGovern, K.A.; OʹBrien, D.F. Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry 1998, 37, 12875– 12883, doi:10.1021/bi980096y.
Corbo, C.; Molinaro, R.; Taraballi, F.; Toledano Furman, N.E.; Sherman, M.B.; Parodi, A.; Salvatore, F.; Tasciotti, E. Effects of the protein corona on liposome-liposome and liposome-cell interactions. Int. J. Nanomed. 2016, 11, 3049–3063, doi:10.2147/IJN.S109059.
Gatenby, R.A.; Gillies, R.J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4, 891–899, doi:10.1038/nrc1478.
Priya James, H.; John, R.; Alex, A.; Anoop, K.R. Smart polymers for the controlled delivery of drugs-a concise overview. Acta Pharm. Sin. B 2014, 4, 120–127, doi:10.1016/j.apsb.2014.02.005.
Tanaka, M.; Fujita, Y.; Onishi, N.; Ogawara, K.-i.; Nakayama, H.; Mukai, T. Preparation and characterization of lipid emulsions containing styrene maleic acid copolymer for the development of pH-responsive drug carriers. Chem. Phys. Lipids 2020, 232, 104954, doi:10.1016/j.chemphyslip.2020.104954.
Lu, P.L.; Chen, Y.C.; Ou, T.W.; Chen, H.H.; Tsai, H.C.; Wen, C.J.; Lo, C.L.; Wey, S.P.; Lin, K.J.; Yen, T.C.; et al. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Biomaterials 2011, 32, 2213–2221, doi:10.1016/j.biomaterials.2010.11.051.
Zavala-Lagunes, E.; Ruiz, J.C.; Varca, G.H.C.; Bucio, E. Synthesis and characterization of stimuli-responsive polypropylene containing N-vinylcaprolactam and N-vinylimidazole obtained by ionizing radiation. Mater. Sci. Eng. 2016, 67, 353–361, doi:10.1016/j.msec.2016.05.044.
Kaneda, Y.; Tsutsumi, Y.; Yoshioka, Y.; Kamada, H.; Yamamoto, Y.; Kodaira, H.; Tsunoda, S.; Okamoto, T.; Mukai, Y.; Shibata, H.; et al. The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials 2004, 25, 3259–3266, doi:10.1016/j.biomaterials.2003.10.003.
Ting, J.M.; Navale, T.S.; Bates, F.S.; Reineke, T.M. Precise Compositional Control and Systematic Preparation of Multimonomeric Statistical Copolymers. ACS Macro Lett. 2013, 2, 770–774, doi:10.1021/mz4003112.
Zhong, Z.; Feijen, J.; Lok, M.C.; Hennink, W.E.; Christensen, L.V.; Yockman, J.W.; Kim, Y.H.; Kim, S.W. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: Synthesis, characterization, and in vitro gene transfer properties. Biomacromolecules 2005, 6, 3440–3448, doi:10.1021/bm050505n.
Duchardt, F.; Fotin-Mleczek, M.; Schwarz, H.; Fischer, R.; Brock, R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 2007, 8, 848–866, doi:10.1111/j.1600-0854.2007.00572.x.
Anderson, H.A.; Chen, Y.; Norkin, L.C. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 1996, 7, 1825–1834, doi:10.1091/mbc.7.11.1825.
Patino, T.; Soriano, J.; Barrios, L.; Ibanez, E.; Nogues, C. Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells. Sci. Rep. 2015, 5, 1–12, doi:10.1038/srep11371.
Passirani, C.; Barratt, G.; Devissaguet, J.P.; Labarre, D. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci. 1998, 62, 775–785, doi:10.1016/S0024-3205(97)01175- 2.
Pohlert, T. The Pairwise Multiple Comparison of Mean Ranks Package (PMCMR). Availabe online: https://CRAN.R-project.org/package=PMCMR (accessed on 01 December 2018).
Vonarbourg, A.; Passirani, C.; Saulnier, P.; Simard, P.; Leroux, J.C.; Benoit, J.P. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J. Biomed. Mater. Res. Part A 2006, 78, 620-628, doi:10.1002/jbm.a.30711.
Koivusalo, M.; Welch, C.; Hayashi, H.; Scott, C.C.; Kim, M.; Alexander, T.; Touret, N.; Hahn, K.M.; Grinstein, S. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 2010, 188, 547–563, doi:10.1083/jcb.200908086.
Rodal, S.K.; Skretting, G.; Garred, O.; Vilhardt, F.; van Deurs, B.; Sandvig, K. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 1999, 10, 961–974, doi:10.1091/mbc.10.4.961.
Grimmer, S.; van Deurs, B.; Sandvig, K. Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J. Cell Sci. 2002, 115, 2953–2962.
Gratton, S.E.; Ropp, P.A.; Pohlhaus, P.D.; Luft, J.C.; Madden, V.J.; Napier, M.E.; DeSimone, J.M. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. USA 2008, 105, 11613–11618, doi:10.1073/pnas.0801763105.
Laine, A.L.; Gravier, J.; Henry, M.; Sancey, L.; Bejaud, J.; Pancani, E.; Wiber, M.; Texier, I.; Coll, J.L.; Benoit, J.P.; et al. Conventional versus stealth lipid nanoparticles: Formulation and in vivo fate prediction through FRET monitoring. J. Control. Release 2014, 188, 1–8, doi:10.1016/j.jconrel.2014.05.042.
Hadinoto, K.; Sundaresan, A.; Cheow, W.S. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review. Eur. J. Pharm. Biopharm. 2013, 85, 427–443, doi:10.1016/j.ejpb.2013.07.002.
Velasco, D.; Rethore, G.; Newland, B.; Parra, J.; Elvira, C.; Pandit, A.; Rojo, L.; San Roman, J. Low polydispersity (N-ethyl pyrrolidine methacrylamide-co-1-vinylimidazole) linear oligomers for gene therapy applications. Eur. J. Pharm. Biopharm. 2012, 82, 465–474, doi:10.1016/j.ejpb.2012.08.002.
Tarley, C.R.T.; Corazza, M.Z.; Somera, B.F.; Segatelli, M.G. Preparation of new ion-selective cross-linked poly(vinylimidazole-co-ethylene glycol dimethacrylate) using a double-imprinting process for the preconcentration of Pb2+ ions. J. Colloid Interface Sci. 2015, 450, 254–263, doi:10.1016/j.jcis.2015.02.074.
Liu, G.; Li, Y.; Sheth, V.R.; Pagel, M.D. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. Mol. Imaging 2012, 11, 47–57.
Boussif, O.; Lezoualcʹh, F.; Zanta, M.A.; Mergny, M.D.; Scherman, D.; Demeneix, B.; Behr, J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA 1995, 92, 7297–7301, doi:10.1073/pnas.92.16.7297.
Asayama, S.; Nishinohara, S.; Kawakami, H. Zinc-chelated poly(1-vinylimidazole) and a carbohydrate ligand polycation form DNA ternary complexes for gene delivery. Bioconjug. Chem. 2011, 22, 1864–1868, doi:10.1021/bc2003378.
Hakamatani, T.; Asayama, S.; Kawakami, H. Synthesis of alkylated poly(1-vinylimidazole) for a new pH-sensitive DNA carrier. Nucleic Acids Symp. Ser. (Oxf) 2008, 52, 677–678, doi:10.1093/nass/nrn342.
David, S.; Resnier, P.; Guillot, A.; Pitard, B.; Benoit, J.P.; Passirani, C. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration. Eur. J. Pharm. Biopharm. 2012, 81, 448–452, doi:10.1016/j.ejpb.2012.02.010.
Topin-Ruiz, S.; Mellinger, A.; Lepeltier, E.; Bourreau, C.; Fouillet, J.; Riou, J.; Jaouen, G.; Martin, L.; Passirani, C.; Clere, N. p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes. Int. J. Pharm. 2021, 593, 120111, doi:10.1016/j.ijpharm.2020.120111.
Kierstead, P.H.; Okochi, H.; Venditto, V.J.; Chuong, T.C.; Kivimae, S.; Frechet, J.M.J.; Szoka, F.C. The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes. J. Control. Release 2015, 213, 1–9, doi:10.1016/j.jconrel.2015.06.023.
Ishihara, T.; Maeda, T.; Sakamoto, H.; Takasaki, N.; Shigyo, M.; Ishida, T.; Kiwada, H.; Mizushima, Y.; Mizushima, T. Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers. Biomacromolecules 2010, 11, 2700–2706, doi:10.1021/bm100754e.
Mayer, A.; Vadon, M.; Rinner, B.; Novak, A.; Wintersteiger, R.; Frohlich, E. The role of nanoparticle size in hemocompatibility. Toxicology 2009, 258, 139–147, doi:10.1016/j.tox.2009.01.015.
Gundel, D.; Allmeroth, M.; Reime, S.; Zentel, R.; Thews, O. Endocytotic uptake of HPMA-based polymers by different cancer cells: Impact of extracellular acidosis and hypoxia. Int. J. Nanomed. 2017, 12, 5571–5584, doi:10.2147/IJN.S136952.
Resnier, P.; Galopin, N.; Sibiril, Y.; Clavreul, A.; Cayon, J.; Briganti, A.; Legras, P.; Vessières, A.; Montier, T.; Jaouen, G.; et al. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse. Pharmacol. Res. 2017, 126, 54–65, doi:10.1016/j.phrs.2017.01.031.
Karim, R.; Lepeltier, E.; Esnault, L.; Pigeon, P.; Lemaire, L.; Lépinoux-Chambaud, C.; Clere, N.; Jaouen, G.; Eyer, J.; Piel, G.; et al. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: Effect of a surface-functionalizing NFL peptide. Nanoscale 2018, 10, 13485–13501, doi:10.1039/C8NR02132E.
Resnier, P.; Lepeltier, E.; Emina, A.L.; Galopin, N.; Bejaud, J.; David, S.; Ballet, C.; Benvegnu, T.; Pecorari, F.; Chourpa, I.; et al. Model Affitin and PEG modifications onto siRNA lipid nanocapsules: Cell uptake and in vivo biodistribution improvements. RSC Adv. 2019, 9, 27264–27278, doi:10.1039/C9RA03668G.
Yang, Q.; Jacobs, T.M.; McCallen, J.D.; Moore, D.T.; Huckaby, J.T.; Edelstein, J.N.; Lai, S.K. Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population. Anal. Chem. 2016, 88, 11804–11812, doi:10.1021/acs.analchem.6b03437.
Torchilin, V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 2011, 63, 131–135, doi:10.1016/j.addr.2010.03.011.
Martinez-Zaguilan, R.; Seftor, E.A.; Seftor, R.E.; Chu, Y.W.; Gillies, R.J.; Hendrix, M.J. Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 1996, 14, 176–186, doi:10.1007/bf00121214.
